FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original Abbreviated New Drug Application for rosuvastatin calcium from Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia Heterozygous
• Familial Hypercholesterolemia Homozygous
• Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

ORIG AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)